Aehr Cost of Revenue vs Free Cash Flow Analysis

AEHR Stock

USD 11.15 0.44 3.80%

Aehr Test financial indicator trend analysis is way more than just evaluating Aehr Test Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aehr Test Systems is a good investment. Please check the relationship between Aehr Test Cost Of Revenue and its Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Cost Of Revenue vs Free Cash Flow

Cost of Revenue vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aehr Test Systems Cost of Revenue account and Free Cash Flow. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Aehr Test's Cost of Revenue and Free Cash Flow is 0.91. Overlapping area represents the amount of variation of Cost of Revenue that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Aehr Test Systems, assuming nothing else is changed. The correlation between historical values of Aehr Test's Cost of Revenue and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cost of Revenue of Aehr Test Systems are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of Cost of Revenue i.e., Aehr Test's Cost of Revenue and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.91

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Cost Of Revenue

Cost of Revenue is found on Aehr Test Systems income statement and represents the costs associated with goods and services Aehr Test provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Aehr Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aehr Test Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

At this time, Aehr Test's Tax Provision is relatively stable compared to the past year. As of 04/17/2024, Enterprise Value Over EBITDA is likely to grow to 63.14, while Selling General Administrative is likely to drop slightly above 8.4 M.

	2021	2022	2023	2024 (projected)
Gross Profit	23.7M	32.7M	37.7M	39.5M
Total Revenue	50.8M	65.0M	74.7M	78.4M

Gross Profit Total Revenue

Aehr Test fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Current Deferred Revenue	Common Stock Total Equity	Short Term Investments
Total Assets		0.57	0.53	0.91	0.98	0.96	-0.83	0.08	0.97	0.94	0.94	-0.21	0.99	0.97	0.83	0.65	0.99	0.1	0.89	0.92	0.96	1.0	-0.3	0.48	0.7	0.79
Short Long Term Debt Total	0.57		0.24	0.63	0.47	0.65	-0.25	-0.01	0.6	0.48	0.65	0.02	0.56	0.46	0.51	0.77	0.58	0.29	0.51	0.77	0.65	0.56	0.04	0.34	0.55	0.58
Other Current Liab	0.53	0.24		0.67	0.57	0.47	-0.46	0.49	0.61	0.45	0.55	0.49	0.46	0.65	0.27	0.08	0.56	0.63	0.27	0.53	0.47	0.53	0.17	-0.05	0.17	0.72
Total Current Liabilities	0.91	0.63	0.67		0.86	0.86	-0.68	0.35	0.94	0.81	0.87	0.16	0.87	0.91	0.64	0.51	0.91	0.41	0.68	0.94	0.86	0.9	0.04	0.37	0.52	0.88
Total Stockholder Equity	0.98	0.47	0.57	0.86		0.91	-0.89	0.02	0.92	0.95	0.92	-0.24	0.98	0.96	0.84	0.56	0.96	0.06	0.9	0.85	0.91	0.98	-0.3	0.44	0.72	0.73
Property Plant And Equipment Net	0.96	0.65	0.47	0.86	0.91		-0.66	0.1	0.96	0.82	0.99	-0.23	0.93	0.93	0.79	0.72	0.97	0.08	0.85	0.92	1.0	0.95	-0.31	0.38	0.67	0.83
Net Debt	-0.83	-0.25	-0.46	-0.68	-0.89	-0.66		0.18	-0.7	-0.95	-0.66	0.31	-0.88	-0.8	-0.79	-0.38	-0.76	0.05	-0.84	-0.65	-0.66	-0.84	0.29	-0.52	-0.71	-0.42
Retained Earnings	0.08	-0.01	0.49	0.35	0.02	0.1	0.18		0.26	-0.1	0.12	0.75	-0.01	0.18	-0.44	-0.07	0.14	0.66	-0.37	0.22	0.1	0.07	0.18	-0.08	-0.58	0.59
Accounts Payable	0.97	0.6	0.61	0.94	0.92	0.96	-0.7	0.26		0.84	0.95	-0.07	0.93	0.97	0.71	0.64	0.98	0.24	0.78	0.94	0.96	0.96	-0.24	0.38	0.58	0.89
Cash	0.94	0.48	0.45	0.81	0.95	0.82	-0.95	-0.1	0.84		0.8	-0.29	0.97	0.89	0.85	0.58	0.88	0.02	0.91	0.83	0.82	0.95	-0.28	0.57	0.77	0.58
Non Current Assets Total	0.94	0.65	0.55	0.87	0.92	0.99	-0.66	0.12	0.95	0.8		-0.17	0.91	0.92	0.77	0.69	0.96	0.14	0.82	0.91	0.99	0.94	-0.26	0.33	0.65	0.86
Non Currrent Assets Other	-0.21	0.02	0.49	0.16	-0.24	-0.23	0.31	0.75	-0.07	-0.29	-0.17		-0.29	-0.11	-0.48	-0.4	-0.16	0.87	-0.53	-0.04	-0.23	-0.21	0.69	-0.39	-0.48	0.3
Cash And Short Term Investments	0.99	0.56	0.46	0.87	0.98	0.93	-0.88	-0.01	0.93	0.97	0.91	-0.29		0.94	0.84	0.67	0.96	0.02	0.91	0.91	0.93	0.99	-0.33	0.55	0.73	0.71
Net Receivables	0.97	0.46	0.65	0.91	0.96	0.93	-0.8	0.18	0.97	0.89	0.92	-0.11	0.94		0.78	0.53	0.97	0.2	0.83	0.87	0.93	0.97	-0.26	0.36	0.64	0.82
Common Stock Shares Outstanding	0.83	0.51	0.27	0.64	0.84	0.79	-0.79	-0.44	0.71	0.85	0.77	-0.48	0.84	0.78		0.5	0.81	-0.17	0.98	0.67	0.79	0.83	-0.2	0.33	0.96	0.4
Non Current Liabilities Total	0.65	0.77	0.08	0.51	0.56	0.72	-0.38	-0.07	0.64	0.58	0.69	-0.4	0.67	0.53	0.5		0.63	-0.08	0.6	0.78	0.72	0.64	-0.57	0.63	0.48	0.52
Inventory	0.99	0.58	0.56	0.91	0.96	0.97	-0.76	0.14	0.98	0.88	0.96	-0.16	0.96	0.97	0.81	0.63		0.13	0.86	0.92	0.97	0.98	-0.27	0.42	0.66	0.83
Other Current Assets	0.1	0.29	0.63	0.41	0.06	0.08	0.05	0.66	0.24	0.02	0.14	0.87	0.02	0.2	-0.17	-0.08	0.13		-0.2	0.27	0.08	0.1	0.48	-0.21	-0.14	0.52
Other Stockholder Equity	0.89	0.51	0.27	0.68	0.9	0.85	-0.84	-0.37	0.78	0.91	0.82	-0.53	0.91	0.83	0.98	0.6	0.86	-0.2		0.74	0.85	0.89	-0.35	0.45	0.92	0.46
Total Liab	0.92	0.77	0.53	0.94	0.85	0.92	-0.65	0.22	0.94	0.83	0.91	-0.04	0.91	0.87	0.67	0.78	0.92	0.27	0.74		0.92	0.92	-0.2	0.53	0.57	0.85
Property Plant And Equipment Gross	0.96	0.65	0.47	0.86	0.91	1.0	-0.66	0.1	0.96	0.82	0.99	-0.23	0.93	0.93	0.79	0.72	0.97	0.08	0.85	0.92		0.95	-0.31	0.38	0.67	0.83
Total Current Assets	1.0	0.56	0.53	0.9	0.98	0.95	-0.84	0.07	0.96	0.95	0.94	-0.21	0.99	0.97	0.83	0.64	0.98	0.1	0.89	0.92	0.95		-0.3	0.49	0.7	0.77
Short Term Debt	-0.3	0.04	0.17	0.04	-0.3	-0.31	0.29	0.18	-0.24	-0.28	-0.26	0.69	-0.33	-0.26	-0.2	-0.57	-0.27	0.48	-0.35	-0.2	-0.31	-0.3		-0.56	-0.14	-0.06
Current Deferred Revenue	0.48	0.34	-0.05	0.37	0.44	0.38	-0.52	-0.08	0.38	0.57	0.33	-0.39	0.55	0.36	0.33	0.63	0.42	-0.21	0.45	0.53	0.38	0.49	-0.56		0.3	0.23
Common Stock Total Equity	0.7	0.55	0.17	0.52	0.72	0.67	-0.71	-0.58	0.58	0.77	0.65	-0.48	0.73	0.64	0.96	0.48	0.66	-0.14	0.92	0.57	0.67	0.7	-0.14	0.3		0.26
Short Term Investments	0.79	0.58	0.72	0.88	0.73	0.83	-0.42	0.59	0.89	0.58	0.86	0.3	0.71	0.82	0.4	0.52	0.83	0.52	0.46	0.85	0.83	0.77	-0.06	0.23	0.26

Click cells to compare fundamentals

Aehr Test Account Relationship Matchups

Aehr Test fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	20.6M	21.7M	62.3M	98.1M	112.9M	118.5M
Other Current Liab	1.4M	2.2M	3.6M	4.1M	3.7M	1.9M
Total Current Liabilities	3.9M	9.1M	11.0M	16.3M	18.8M	19.7M
Total Stockholder Equity	14.1M	11.4M	51.0M	75.6M	68.0M	71.4M
Property Plant And Equipment Net	2.8M	2.3M	2.1M	8.9M	10.2M	10.7M
Net Debt	(1.5M)	241K	(30.5M)	(23.8M)	(21.4M)	(20.3M)
Retained Earnings	(74.3M)	(76.3M)	(66.9M)	(52.3M)	(47.1M)	(49.4M)
Accounts Payable	945K	2.9M	4.2M	9.2M	10.6M	11.1M
Cash	5.4M	4.6M	31.5M	30.1M	34.6M	36.3M
Non Current Assets Total	2.9M	2.5M	2.3M	9.1M	8.2M	8.6M
Non Currrent Assets Other	73K	118K	121K	81K	72.9K	69.3K
Cash And Short Term Investments	5.4M	4.6M	31.5M	47.9M	55.1M	57.8M
Net Receivables	3.7M	5.2M	12.9M	16.6M	19.1M	20.0M
Common Stock Shares Outstanding	22.9M	23.5M	27.8M	29.2M	33.6M	35.3M
Liabilities And Stockholders Equity	20.6M	21.7M	62.3M	98.1M	112.9M	118.5M
Non Current Liabilities Total	2.7M	1.2M	325K	6.2M	7.2M	7.5M
Inventory	8.0M	8.8M	15.1M	23.9M	27.5M	28.9M
Other Current Assets	512K	551K	613K	621K	558.9K	861.9K
Other Stockholder Equity	85.9M	87.6M	117.7M	127.8M	146.9M	154.3M
Total Liab	6.5M	10.2M	11.3M	22.5M	25.9M	27.2M
Property Plant And Equipment Gross	2.8M	2.3M	2.1M	8.9M	10.2M	10.7M
Total Current Assets	17.7M	19.2M	60.0M	89.0M	102.4M	107.5M
Accumulated Other Comprehensive Income	2.2M	(28K)	(105K)	(155K)	(178.3K)	(169.3K)
Current Deferred Revenue	170K	189K	2.4M	2.8M	3.2M	3.4M
Common Stock Total Equity	221K	227K	231K	237K	272.6K	286.2K
Common Stock	231K	237K	271K	285K	327.8K	344.1K
Other Liab	22K	148K	113K	72K	64.8K	61.6K
Other Assets	153K	198K	201K	231K	207.9K	380.5K
Property Plant Equipment	2.8M	2.3M	2.1M	8.9M	10.2M	10.7M
Net Tangible Assets	14.1M	11.4M	51.0M	75.6M	86.9M	91.3M
Retained Earnings Total Equity	(66.2M)	(71.5M)	(74.3M)	(76.3M)	(68.7M)	(72.1M)
Capital Surpluse	85.9M	87.6M	117.7M	127.8M	146.9M	85.6M
Deferred Long Term Liab	522K	342K	22K	99K	113.9K	173.1K

Pair Trading with Aehr Test

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.

Moving together with Aehr Stock

0.72

MagnaChip Semiconductor Financial Report 1st of May 2024

Pair Corr

Moving against Aehr Stock

0.9	MU	Micron Technology Financial Report 26th of June 2024	Pair Corr
0.82	DM	Desktop Metal Financial Report 8th of May 2024	Pair Corr
0.77	ML	MoneyLion Financial Report 14th of May 2024	Pair Corr
0.72	PI	Impinj Inc Earnings Call This Week	Pair Corr
0.72	GB	Global Blue Group	Pair Corr

The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.

The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Aehr Test Systems is a strong investment it is important to analyze Aehr Test's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aehr Test's future performance. For an informed investment choice regarding Aehr Stock, refer to the following important reports:

How To Invest In Aehr

Details

Is Aehr Stock a good investment?

Details

What is Aehr Test's Net Worth?

Details

Largest Semiconductors & Semiconductor Equipment Companies

View

Largest Information Technology Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.

Note that the Aehr Test Systems information on this page should be used as a complementary analysis to other Aehr Test's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Investment Finder module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Aehr Stock analysis

When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.

	Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators

Is Aehr Test's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aehr Test. If investors know Aehr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aehr Test listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.538

Earnings Share

0.52

Revenue Per Share

2.506

Quarterly Revenue Growth

(0.56)

Return On Assets

0.0885

The market value of Aehr Test Systems is measured differently than its book value, which is the value of Aehr that is recorded on the company's balance sheet. Investors also form their own opinion of Aehr Test's value that differs from its market value or its book value, called intrinsic value, which is Aehr Test's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aehr Test's market value can be influenced by many factors that don't directly affect Aehr Test's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aehr Test's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aehr Test is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aehr Test's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Aehr Cost of Revenue vs Free Cash Flow Analysis

Cost Of Revenue vs Free Cash Flow

Cost of Revenue vs Free Cash Flow Correlation Analysis

Correlation Coefficient

Cost Of Revenue

Free Cash Flow

Aehr Test fundamental ratios Correlations

Aehr Test Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Aehr Test fundamental ratios Accounts

Pair Trading with Aehr Test

Moving together with Aehr Stock

Moving against Aehr Stock

Complementary Tools for Aehr Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 0.99	Total Assets
Inventory	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 0.99	Non Current Assets Total

Cash	- 0.95	Net Debt
Net Debt	- 0.89	Total Stockholder Equity
Cash And Short Term Investments	- 0.88	Net Debt
Total Current Assets	- 0.84	Net Debt
Other Stockholder Equity	- 0.84	Net Debt
Net Debt	- 0.83	Total Assets